The role of the pharmacist in supporting multi-disciplinary education

Effective communication about biosimilars

Realising the potential of biosimilars

Comment: Supporting a sustainable biosimilar solution

Comment: Use of biosimilar monoclonal antibodies in the clinic

Comment: Critical quality attributes of biosimilars

Comment: Immunogenicity of biosimilars

Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma

PARP inhibitors for metastatic breast cancer

KATHERINE trial updates for HER2-positive breast cancer

Lutetium-177 PSMA scanning for prostate cancer